Request for the identities of members of the public making submissions and PHARMAC staff involved in decision making on funding of drug
Tony Wall made a request to PHARMAC for information about the decision to fund the blood thinning drug dabigatran. PHARMAC released much of the information requested, but refused to provide the identities of members of the public making submissions and some PHARMAC staff involved in decision making on the drug. In refusing this information, PHARMAC relied on sections 9(2)(a), 9(2)(g)(i) and 9(2)(g)(ii) of the Official Information Act (OIA). Based on the information before me, I have now formed the opinion that these sections did not provide good reason to refuse the request for this information. Given that PHARMAC has indicated it is now prepared to release the information, I do not intend to make any recommendations in this case.